Clasp Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 05, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $150,000,000
Company Info
- Founders
- Robert Ross
- Company Description
- At Clasp Therapeutics, we are expanding the reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type. This approach enables a highly selective paradigm where every patient has the opportunity to respond to treatment.
- Market
- Immuno-oncology
- Location
- Rockville, MD, USA
- Coinvestors
- Alexandria Venture Investments, Blackbird Ventures, BrightEdge Fund, Catalio Capital, Cure Ventures, Novo Holdings, Pictet, Third Rock Ventures, Vivo Capital